X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse GSK Consumer with THE COCA COLA COMPANY - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs COCA COLA (US) - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

COCA COLA (US)
   Change

The Coca Cola Company is the world’s largest beverage company. It owns and markets more than 500 non-alcoholic beverage brands including soft drinks, fruit juices, sport drinks and other beverages. It has four of the world’s top five sparkling bevera... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK CONSUMER   COCA COLA
EQUITY SHARE DATA
    GSK CONSUMER
Mar-16
COCA COLA
Dec-14
GSK CONSUMER/
COCA COLA
5-Yr Chart
Click to enlarge
High Rs6,7712,886-   
Low Rs5,4482,367-   
Sales per share (Unadj.) Rs1,024.4675.7-  
Earnings per share (Unadj.) Rs163.3104.3-  
Cash flow per share (Unadj.) Rs177.0133.3-  
Dividends per share (Unadj.) Rs70.0076.97-  
Dividend yield (eoy) %1.12.9 39.1%  
Book value per share (Unadj.) Rs581.5445.4-  
Shares outstanding (eoy) m42.064,366.00-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x6.03.9 153.4%   
Avg P/E ratio x37.425.2 148.5%  
P/CF ratio (eoy) x34.519.7 175.2%  
Price / Book Value ratio x10.55.9 178.2%  
Dividend payout %42.973.8 58.1%   
Avg Mkt Cap Rs m256,95911,467,443 2.2%   
No. of employees `0003.7129.2 2.9%   
Total wages/salary Rs m5,0940-   
Avg. sales/employee Rs Th11,548.522,835.2 50.6%   
Avg. wages/employee Rs Th1,365.30-   
Avg. net profit/employee Rs Th1,841.13,523.7 52.2%   
INCOME DATA
Net Sales Rs m43,0872,950,312 1.5%  
Other income Rs m2,7886,414 43.5%   
Total revenues Rs m45,8752,956,726 1.6%   
Gross profit Rs m8,349749,412 1.1%  
Depreciation Rs m574126,741 0.5%   
Interest Rs m830,980 0.0%   
Profit before tax Rs m10,554598,106 1.8%   
Minority Interest Rs m0-1,668 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,685141,172 2.6%   
Profit after tax Rs m6,869455,266 1.5%  
Gross profit margin %19.425.4 76.3%  
Effective tax rate %34.923.6 147.9%   
Net profit margin %15.915.4 103.3%  
BALANCE SHEET DATA
Current assets Rs m37,5602,115,722 1.8%   
Current liabilities Rs m18,1532,076,468 0.9%   
Net working cap to sales %45.01.3 3,385.4%  
Current ratio x2.11.0 203.1%  
Inventory Days Days3925 159.0%  
Debtors Days Days3035 84.7%  
Net fixed assets Rs m5,374938,561 0.6%   
Share capital Rs m421112,886 0.4%   
"Free" reserves Rs m24,0030-   
Net worth Rs m24,4561,944,725 1.3%   
Long term debt Rs m01,222,701 0.0%   
Total assets Rs m44,9885,902,355 0.8%  
Interest coverage x1,336.920.3 6,583.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.00.5 191.6%   
Return on assets %15.38.2 185.6%  
Return on equity %28.123.4 120.0%  
Return on capital %43.219.8 218.0%  
Exports to sales %5.10-   
Imports to sales %0.40-   
Net fx Rs m2,5550-   
CASH FLOW
From Operations Rs m5,724680,846 0.8%  
From Investments Rs m-1,569-481,435 0.3%  
From Financial Activity Rs m-2,792-232,892 1.2%  
Net Cashflow Rs m1,363-33,481 -4.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for COCA COLA (US) is United States Dollars. All data has been converted at 64.14 Rs / USD

Compare GSK CONSUMER With: NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  

Compare GSK CONSUMER With: AGRO TECH FOODS  ZYDUS WELLNESS  VADILAL INDUSTRIES  GOODRICKE  KWALITY DAIRY  



Today's Market

Sensex Plummets 390 Points; Infosys Continues to Fall(01:30 pm)

After opening the day on a negative note, the share markets in India continued to witness selling pressure as Infosys cracked after Vishal Sikka's resignation as MD & CEO.

Related Views On News

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

GSK Consumer: Slowdown in demand impacts sales (Quarterly Results Update - Detailed)

Oct 5, 2016

GSK Consumer Healthcare has announced the first quarter results of the financial year 2016-2017 (1QFY17). The company's sales declined by 1.4% YoY while net profit rose by 2.9% YoY during the quarter.

GSK Consumer: A Forgetful Year (Quarterly Results Update - Detailed)

Jun 1, 2016

GSK Consumer Healthcare announced its results for the quarter and year ended March 2016. During the quarter, sales and profit came in lower by 9% YoY and 8% YoY respectively.

GSK Consumer: Feeling the Growth Pressures? (Quarterly Results Update - Detailed)

Feb 15, 2016

GSK Consumer Healthcare announced its results for the quarter ended December 2015. While revenues were up by 2% YoY, profits were higher by 37% YoY.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Aug 18, 2017 03:37 PM

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS